ANTIBODIES AND ANTI-ANTIBODIES TO STEROID HORMONES, AND BREAST CANCER RISK

Autor: A. N. Glushkov, E. G. Polenok, M. V. Kostyanko, A. V. Antonov, N. E. Verzhbitskaya, I. A. Vafin, S. E. Ragozhina
Jazyk: ruština
Rok vydání: 2017
Předmět:
Zdroj: Медицинская иммунология, Vol 19, Iss 5, Pp 577-584 (2017)
Druh dokumentu: article
ISSN: 1563-0625
2313-741X
DOI: 10.15789/1563-0625-2017-5-577-584
Popis: Antibodies against sex steroid hormones are known to modulate their serum concentration and inhibit experimental breast cancer (BC). Hence, these effects could be changed by according anti-idiotypic antibodies. However, relationships between antibodies and anti-idiotypic antibodies and BC in women are still poorly studied. The aim of this study was to identify possible associations between occurrence of antibodies against estradiol and progesterone (IgG-Es1and IgG-Pg1) and according antiidiotypic antibodies (IgG-Es2 and IgG-Pg2), and postmenopausal BC. Eighty-nine healthy women and 273 BC patients were examined. A non-competitive solid phase immunoassay for IgG-Es1 and IgG-Pg1 was performed using estradiol and progesterone conjugates with bovin serum albumin as antigens. Monoclonal antibodies against Es and Pg as antigens have been used for noncompetitive solid phase immunoassay of IgG-Es2 and IgG-Pg2. Results: absence of both IgG-Es1 and IgG-Pg1 was revealed in 53.9% of healthy donors and 41.0% of BC patients (p = 0.04; OR = 0.6). Presence of IgG-Es1 without IgG-Pg1, or IgG-Pg1 without IgG-Es1was detected for, respectively, 15.7% and 20.2% of healthy women, and in 10.3% and 7.7% of BC patients (p > 0.05). Simultaneous increase of both IgG-Es1 and IgG-Pg1 was revealed in 10.1% of healthy donors and in 41.0% of BC patients (p < 0.0001; OR = 5.3). Absence of a single antibogy (IgG-Es2 or IgG-Pg2) showed similar frequency in the groups under study. Simultaneous increase of both IgG-Es2 and IgG-Pg2 was detected in 52.8% of healthy women and 34.8% of BC patients (p = 0.03; OR = 0.4). Conclusion: We have first revealed an immunostimulating synergistic effect of antibodies against sex steroid hormones and immunoinhibitory synergistic effect of appropriate anti-idiotypic antibodies upon the postmenopausal breast cancer risk.
Databáze: Directory of Open Access Journals
Externí odkaz: